News

Vertex raises 2025 revenue guidance to $12B with strong launches and pipeline progress
Discover Vertex Pharmaceuticals' Q1 2025 earnings insights, with 3% revenue growth, key product launches like JOURNAVX & ALYFTREK, & raised ...